Letters to the editor: Use optometry resources; In need of VT charts

Article

I am disappointed that Optometry Times would choose to suggest its readers use a pediatric “vision” check list from Bascom Palmer.

Use optometry resources, please

I am disappointed that Optometry Times would choose to suggest its readers use a pediatric “vision” check list from Bascom Palmer (“Share this pediatric vision checklist with your patients,” News Flash August 9, 2014) and not one from the American Optometric Association (AOA) (such as the convergence insufficiency checklist) or from College of Optometrists in Vision Development (COVD) or Optometric Extension Program (OEP). 

Please use optometric-based checklists.

Diane Serex-Dougan, OD, FCOVD

Parkville, MD

 

In need of VT charts

Where can I purchase the VT Hart charts mentioned in Dr. Marc Taub’s article (“Vision therapy: A top 10 must-have list,” August 2014)? I have not been able to find the small ones used for near.

Melissa Holliman, OD

Kingsport, TN

Marc Taub replies:

The Hart charts can be generated from a computer program called Vision Builder distributed by OEP. You can make different sorts of charts with different numbers of columns and rows.

You can get the program at www.oepf.org.

Recent Videos
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.